Metabolite List
metabolites which its exact mass nearly 452.1107 with tolerance error 0.01 da.
2-[4-(benzenesulfonyl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole (BioCAD00000508953)
Formula: C23H20N2O6S (Exact Mass: 452.1042)
(2R)-4-[6-(2-fluoro-4-methoxyphenyl)-2-oxo-1,3-benzoxazol-3-yl]-N-hydroxy-2-methyl-2-methylsulfonylbutanamide (BioCAD00000646355)
Formula: C20H21FN2O7S (Exact Mass: 452.1053)
2,2-dichloro-N-[[(5S)-2-oxo-3-[4-[(3,5,6-trimethylpyrazin-2-yl)methoxy]phenyl]-1,3-oxazolidin-5-yl]methyl]acetamide (BioCAD00000689844)
Formula: C20H22Cl2N4O4 (Exact Mass: 452.1018)
[4-(4-methylphenyl)-2-(N-phenylanilino)-1,3-thiazol-5-yl]-thiophen-2-ylmethanone (BioCAD00000690583)
Formula: C27H20N2OS2 (Exact Mass: 452.1017)
dibenzofuran (DBF) scaffold, (S)-18 (BioCAD00000700439)
Formula: C20H21FN2O7S (Exact Mass: 452.1053)
dibenzofuran (DBF) scaffold, (S)-28 (BioCAD00000701801)
Formula: C20H21FN2O7S (Exact Mass: 452.1053)
1,2-Dichloroethane (Dehydration, Oxidative Dechlorination, Cysteine Conjugation 1, GSH Conjugation (on Chlorine)) (BioCAD00000785020)
Formula: C15 H24 N4 O8 S2 (Exact Mass: 452.1036)
Rovazolac (BioCAD00001346816)
Formula: C21H19F3N2O4S (Exact Mass: 452.1018)
Rovazolac is under investigation in clinical trial NCT03175354 (A Study in Subjects With Moderate Atopic Dermatitis).